Walleye Capital LLC Brainstorm Cell Therapeutics Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 03, 2022	SELL	$2.81 - $4.23 $29,895 - $45,002	-10,639 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.14 - $4.09 $33,406 - $43,513	10,639 New	10,639 $35,000
Q1 2021 May 17, 2021	SELL	$3.46 - $7.88 $55,948 - $127,419	-16,170 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.99 - $17.73 $64,518 - $286,694	16,170 New	16,170 $73,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $56.6M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.